Sfoglia per Autore
Real-vs-virtual phenotype: 16 week results of a multicentre randomised trial (The Genpherex Study)
2001-01-01 Mazzotta, F; LO CAPUTO, S; Scudeller, L; Torti, Carlo; Castelli, Francesco; Carosi, Giampiero
I data-base clinici e la sorveglianza degli eventi avversi: il progetto MASTER
2001-01-01 Castelli, Francesco; Puoti, Massimo; Torti, Carlo; Patroni, A.; Carosi, Giampiero; GRUPPO DI STUDIO, Master
Co-infezione HIV-HCV e dislipidemie in corso di Highly Active Antiretroviral Therapy (HAART)
2001-01-01 Patroni, Andrea; Torti, Carlo; Castelli, Francesco; Tomasoni, L; Pan, A; QUIROS ROLDAN, Maria Eugenia; Puoti, Massimo; Carosi, Giampiero
La risposta viro-immunologica discordante nella pratica clinica
2001-01-01 Tomasoni, L; Torti, Carlo; Patroni, Andrea; Uccelli, M. C.; Gargiulo, F; Castelli, Francesco
Genpherex study: Fenotipo reale versus fenotipo virtuale, valutazione dell'efficacia viro-immunologica
2001-01-01 Mazzotta, F; LO CAPUTO, S; Castelli, Francesco; Angarano, G; Pierotti, P; Torti, Carlo; Ladisa, N; Buccoliero, G; Gianotti, N; Maserati, R; Carosi, Giampiero
R211K and L214F do not invariably confer high level phenotypic resistance to thymidine analogs in zidovudine-naïve patients with M184V
2001-01-01 Torti, Carlo; Gilleece, Y.; Hertogs, K.; Gazzard, B. G.; Pozniak, A.
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy
2001-01-01 QUIROS ROLDAN, Maria Eugenia; Signorini, S.; Castelli, Francesco; Torti, Carlo; Patroni, A.; Airoldi, M.; Carosi, Giampiero
Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy
2002-01-01 QUIROS ROLDAN, Maria Eugenia; Airoldi, M; Moretti, F; Fausti, C; Pan, A; Casari, Salvatore; Torti, Carlo; Castelli, Francesco; Carosi, Giampiero
Influence of hepatitis C virus coinfection on lipid abnormalities in HIV-positive patients after highly active antiretroviral therapy
2002-01-01 Torti, Carlo; Patroni, A; Tinelli, C; Sleiman, I; QUIROS ROLDAN, Maria Eugenia; Puoti, Massimo; Castelli, Francesco
Long-term immunological benefit in patients with discordant responses to therapy depends on both level of viremia and duration of rebound
2002-01-01 Tomasoni, L; Patroni, Andrea; Uccelli, Mc; Gargiulo, F; Torti, Carlo; Carosi, Giampiero; Castelli, Francesco
No evidence of benefical effect of GB virus type C infection on the course of HIV infection.
2002-01-01 QUIROS ROLDAN, Maria Eugenia; Maroto, Mc; Torti, Carlo; Moretti, F; Casari, S; Pan, A; Carosi, Giampiero
Clinical evaluation of rule based and phenotype driven HIV-1 genotype interpretation systems: evidence from the GenPherex Stusy
2002-01-01 Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Keulen, W; Boucher, C; LO CAPUTO, S; Mazzotta, F; Castelli, Francesco; BEEN TIKTAK, A; Pierotti, P; Carosi, Giampiero; Tinelli, C.
Obiettivi della moderna terapia antiretrovirale
2002-01-01 Carosi, Giampiero; Torti, Carlo
Soil transmitted helminth (STH) infections in an indigenous community in Ortigueira, Paraná, Brazil and relationship with its nutritional status
2002-01-01 Beltrame, A; Scolari, C; Torti, Carlo; Urbani, C.
Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study
2002-01-01 Patroni, A; Torti, Carlo; Tomasoni, L; QUIROS ROLDAN, Maria Eugenia; Bertelli, D; Puoti, Massimo; Cadeo, Gp; Sleiman, I; Tinelli, C; Carosi, Giampiero; Castelli, Francesco
HIV pharmacoresistance
2002-01-01 Carosi, Giampiero; Torti, Carlo; QUIROS ROLDAN, Maria Eugenia
Co-infezione HIV-HCV e dislipidemie in corso di terapia antiretrovirale ad elevata efficacia (HAART)
2002-01-01 Patroni, Andrea; Torti, Carlo; Tomasoni, L; QUIROS ROLDAN, Maria Eugenia; Bertelli, D; Puoti, Massimo; Cadeo, G. P.; Sleiman, I; Tinelli, C; Carosi, Giampiero; Castelli, Francesco
Head to head comparison of widely used HIV-1 drug resistance algorithms: Retrogram ® and VGI-Trugene HIV-1 ®
2002-01-01 Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Boucher, C. A. B.; Tinelli, C; BEEN TIKTAK, A. M. M.; LO CAPUTO, S; Mazzotta, F; Castelli, Francesco; Tomasoni, L; Day, S; Carosi, Giampiero
New strategies and new drugs in the salvage therapy for HIV infection
2002-01-01 QUIROS ROLDAN, Maria Eugenia; Torti, Carlo; Pan, A; Carosi, Giampiero
VirtualPhenotype: 12-month Results from the GenPherex Study
2002-01-01 Mazzotta, F; LO CAPUTO, S; Torti, Carlo; Tinelli, C; Castelli, Francesco; Pierotti, P; Angarano, G; Sighinolfi, L; Poggio, A; Gianotti, N; Maserati, R; DE GENNARO, M; Vivarelli, A; Dellefoglie, P; AND CAROSI G., FOR THE GENPHEREX PROUP
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Real-vs-virtual phenotype: 16 week results of a multicentre randomised trial (The Genpherex Study) | 1-gen-2001 | Mazzotta, F; LO CAPUTO, S; Scudeller, L; Torti, Carlo; Castelli, Francesco; Carosi, Giampiero | |
| I data-base clinici e la sorveglianza degli eventi avversi: il progetto MASTER | 1-gen-2001 | Castelli, Francesco; Puoti, Massimo; Torti, Carlo; Patroni, A.; Carosi, Giampiero; GRUPPO DI STUDIO, Master | |
| Co-infezione HIV-HCV e dislipidemie in corso di Highly Active Antiretroviral Therapy (HAART) | 1-gen-2001 | Patroni, Andrea; Torti, Carlo; Castelli, Francesco; Tomasoni, L; Pan, A; QUIROS ROLDAN, Maria Eugenia; Puoti, Massimo; Carosi, Giampiero | |
| La risposta viro-immunologica discordante nella pratica clinica | 1-gen-2001 | Tomasoni, L; Torti, Carlo; Patroni, Andrea; Uccelli, M. C.; Gargiulo, F; Castelli, Francesco | |
| Genpherex study: Fenotipo reale versus fenotipo virtuale, valutazione dell'efficacia viro-immunologica | 1-gen-2001 | Mazzotta, F; LO CAPUTO, S; Castelli, Francesco; Angarano, G; Pierotti, P; Torti, Carlo; Ladisa, N; Buccoliero, G; Gianotti, N; Maserati, R; Carosi, Giampiero | |
| R211K and L214F do not invariably confer high level phenotypic resistance to thymidine analogs in zidovudine-naïve patients with M184V | 1-gen-2001 | Torti, Carlo; Gilleece, Y.; Hertogs, K.; Gazzard, B. G.; Pozniak, A. | |
| Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy | 1-gen-2001 | QUIROS ROLDAN, Maria Eugenia; Signorini, S.; Castelli, Francesco; Torti, Carlo; Patroni, A.; Airoldi, M.; Carosi, Giampiero | |
| Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy | 1-gen-2002 | QUIROS ROLDAN, Maria Eugenia; Airoldi, M; Moretti, F; Fausti, C; Pan, A; Casari, Salvatore; Torti, Carlo; Castelli, Francesco; Carosi, Giampiero | |
| Influence of hepatitis C virus coinfection on lipid abnormalities in HIV-positive patients after highly active antiretroviral therapy | 1-gen-2002 | Torti, Carlo; Patroni, A; Tinelli, C; Sleiman, I; QUIROS ROLDAN, Maria Eugenia; Puoti, Massimo; Castelli, Francesco | |
| Long-term immunological benefit in patients with discordant responses to therapy depends on both level of viremia and duration of rebound | 1-gen-2002 | Tomasoni, L; Patroni, Andrea; Uccelli, Mc; Gargiulo, F; Torti, Carlo; Carosi, Giampiero; Castelli, Francesco | |
| No evidence of benefical effect of GB virus type C infection on the course of HIV infection. | 1-gen-2002 | QUIROS ROLDAN, Maria Eugenia; Maroto, Mc; Torti, Carlo; Moretti, F; Casari, S; Pan, A; Carosi, Giampiero | |
| Clinical evaluation of rule based and phenotype driven HIV-1 genotype interpretation systems: evidence from the GenPherex Stusy | 1-gen-2002 | Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Keulen, W; Boucher, C; LO CAPUTO, S; Mazzotta, F; Castelli, Francesco; BEEN TIKTAK, A; Pierotti, P; Carosi, Giampiero; Tinelli, C. | |
| Obiettivi della moderna terapia antiretrovirale | 1-gen-2002 | Carosi, Giampiero; Torti, Carlo | |
| Soil transmitted helminth (STH) infections in an indigenous community in Ortigueira, Paraná, Brazil and relationship with its nutritional status | 1-gen-2002 | Beltrame, A; Scolari, C; Torti, Carlo; Urbani, C. | |
| Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study | 1-gen-2002 | Patroni, A; Torti, Carlo; Tomasoni, L; QUIROS ROLDAN, Maria Eugenia; Bertelli, D; Puoti, Massimo; Cadeo, Gp; Sleiman, I; Tinelli, C; Carosi, Giampiero; Castelli, Francesco | |
| HIV pharmacoresistance | 1-gen-2002 | Carosi, Giampiero; Torti, Carlo; QUIROS ROLDAN, Maria Eugenia | |
| Co-infezione HIV-HCV e dislipidemie in corso di terapia antiretrovirale ad elevata efficacia (HAART) | 1-gen-2002 | Patroni, Andrea; Torti, Carlo; Tomasoni, L; QUIROS ROLDAN, Maria Eugenia; Bertelli, D; Puoti, Massimo; Cadeo, G. P.; Sleiman, I; Tinelli, C; Carosi, Giampiero; Castelli, Francesco | |
| Head to head comparison of widely used HIV-1 drug resistance algorithms: Retrogram ® and VGI-Trugene HIV-1 ® | 1-gen-2002 | Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Boucher, C. A. B.; Tinelli, C; BEEN TIKTAK, A. M. M.; LO CAPUTO, S; Mazzotta, F; Castelli, Francesco; Tomasoni, L; Day, S; Carosi, Giampiero | |
| New strategies and new drugs in the salvage therapy for HIV infection | 1-gen-2002 | QUIROS ROLDAN, Maria Eugenia; Torti, Carlo; Pan, A; Carosi, Giampiero | |
| VirtualPhenotype: 12-month Results from the GenPherex Study | 1-gen-2002 | Mazzotta, F; LO CAPUTO, S; Torti, Carlo; Tinelli, C; Castelli, Francesco; Pierotti, P; Angarano, G; Sighinolfi, L; Poggio, A; Gianotti, N; Maserati, R; DE GENNARO, M; Vivarelli, A; Dellefoglie, P; AND CAROSI G., FOR THE GENPHEREX PROUP |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile